Joanna Halkias1, Elze Rackaityte2, Sara L Hillman3, Dvir Aran4, Ventura F Mendoza5, Lucy R Marshall6, Tippi C MacKenzie5,7, Trevor D Burt1,5. 1. Division of Neonatology, Department of Pediatrics, and. 2. Biomedical Sciences Program, UCSF, San Francisco, California, USA. 3. Maternal and Fetal Medicine Department, Institute for Women's Health, University College London, London, United Kingdom. 4. Institute for Computational Health Sciences, UCSF, San Francisco, California, USA. 5. Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, UCSF, San Francisco, California, USA. 6. Division of Infection Immunity and Inflammation, University College London Great Ormond Street Institute of Child Health, London, United Kingdom. 7. Department of Surgery, UCSF, San Francisco, California, USA.
Abstract
BACKGROUND: While the human fetal immune system defaults to a program of tolerance, there is concurrent need for protective immunity to meet the antigenic challenges encountered after birth. Activation of T cells in utero is associated with the fetal inflammatory response with broad implications for the health of the fetus and of the pregnancy. However, the characteristics of the fetal effector T cells that contribute to this process are largely unknown. METHODS: We analyzed primary human fetal lymphoid and mucosal tissues and performed phenotypic, functional, and transcriptional analysis to identify T cells with pro-inflammatory potential. The frequency and function of fetal-specific effector T cells was assessed in the cord blood of infants with localized and systemic inflammatory pathologies and compared to healthy term controls. RESULTS: We identified a transcriptionally distinct population of CD4+ T cells characterized by expression of the transcription factor Promyelocytic Leukemia Zinc Finger (PLZF). PLZF+ CD4+ T cells were specifically enriched in the fetal intestine, possessed an effector memory phenotype, and rapidly produced pro-inflammatory cytokines. Engagement of the C-type lectin CD161 on these cells inhibited TCR-dependent production of IFNγ in a fetal-specific manner. IFNγ-producing PLZF+ CD4+ T cells were enriched in the cord blood of infants with gastroschisis, a natural model of chronic inflammation originating from the intestine, as well as in preterm birth, suggesting these cells contribute to fetal systemic immune activation. CONCLUSION: Our work reveals a fetal-specific program of protective immunity whose dysregulation is associated with fetal and neonatal inflammatory pathologies.
BACKGROUND: While the human fetal immune system defaults to a program of tolerance, there is concurrent need for protective immunity to meet the antigenic challenges encountered after birth. Activation of T cells in utero is associated with the fetal inflammatory response with broad implications for the health of the fetus and of the pregnancy. However, the characteristics of the fetal effector T cells that contribute to this process are largely unknown. METHODS: We analyzed primary human fetal lymphoid and mucosal tissues and performed phenotypic, functional, and transcriptional analysis to identify T cells with pro-inflammatory potential. The frequency and function of fetal-specific effector T cells was assessed in the cord blood of infants with localized and systemic inflammatory pathologies and compared to healthy term controls. RESULTS: We identified a transcriptionally distinct population of CD4+ T cells characterized by expression of the transcription factor Promyelocytic Leukemia Zinc Finger (PLZF). PLZF+ CD4+ T cells were specifically enriched in the fetal intestine, possessed an effector memory phenotype, and rapidly produced pro-inflammatory cytokines. Engagement of the C-type lectin CD161 on these cells inhibited TCR-dependent production of IFNγ in a fetal-specific manner. IFNγ-producing PLZF+ CD4+ T cells were enriched in the cord blood of infants with gastroschisis, a natural model of chronic inflammation originating from the intestine, as well as in preterm birth, suggesting these cells contribute to fetal systemic immune activation. CONCLUSION: Our work reveals a fetal-specific program of protective immunity whose dysregulation is associated with fetal and neonatal inflammatory pathologies.
Entities:
Keywords:
Development; Immunology; T cell development
Authors: P J Duggan; E F Maalouf; T L Watts; M H Sullivan; S J Counsell; J Allsop; L Al-Nakib; M A Rutherford; M Battin; I Roberts; A D Edwards Journal: Lancet Date: 2001-11-17 Impact factor: 79.321
Authors: David B Rosen; Jayaram Bettadapura; Mohammed Alsharifi; Porunelloor A Mathew; Hilary S Warren; Lewis L Lanier Journal: J Immunol Date: 2005-12-15 Impact factor: 5.422
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Lesley E Smythies; Marty Sellers; Ronald H Clements; Meg Mosteller-Barnum; Gang Meng; William H Benjamin; Jan M Orenstein; Phillip D Smith Journal: J Clin Invest Date: 2005-01 Impact factor: 14.808
Authors: David Pozo; Mar Valés-Gómez; Nasim Mavaddat; Sharon C Williamson; Susan E Chisholm; Hugh Reyburn Journal: J Immunol Date: 2006-02-15 Impact factor: 5.422
Authors: Maria Ennamorati; Chithirachelvi Vasudevan; Kara Clerkin; Stefan Halvorsen; Smriti Verma; Samira Ibrahim; Shaniah Prosper; Caryn Porter; Vladimir Yeliseyev; Margot Kim; Joseph Gardecki; Slim Sassi; Guillermo Tearney; Bobby J Cherayil; Lynn Bry; Brian Seed; Nitya Jain Journal: Proc Natl Acad Sci U S A Date: 2020-01-21 Impact factor: 11.205
Authors: Jessica M Toothaker; Oluwabunmi Olaloye; Blake T McCourt; Collin C McCourt; Tatiana N Silva; Rebecca M Case; Peng Liu; Dean Yimlamai; George Tseng; Liza Konnikova Journal: Development Date: 2022-02-17 Impact factor: 6.868
Authors: Jessica M Toothaker; Pietro Presicce; Monica Cappelletti; Stephanie F Stras; Collin C McCourt; Claire A Chougnet; Suhas G Kallapur; Liza Konnikova Journal: Front Immunol Date: 2020-05-22 Impact factor: 7.561
Authors: Na Li; Vincent van Unen; Nannan Guo; Tamim Abdelaal; Antonios Somarakis; Jeroen Eggermont; Ahmed Mahfouz; Susana M Chuva de Sousa Lopes; Boudewijn P F Lelieveldt; Frits Koning Journal: Front Immunol Date: 2019-08-14 Impact factor: 7.561
Authors: E Rackaityte; J Halkias; E M Fukui; V F Mendoza; C Hayzelden; E D Crawford; K E Fujimura; T D Burt; S V Lynch Journal: Nat Med Date: 2020-02-24 Impact factor: 53.440
Authors: Miqdad O Dhariwala; Dhuvarakesh Karthikeyan; Kimberly S Vasquez; Sepideh Farhat; Antonin Weckel; Keyon Taravati; Elizabeth G Leitner; Sean Clancy; Mariela Pauli; Merisa L Piper; Jarish N Cohen; Judith F Ashouri; Margaret M Lowe; Michael D Rosenblum; Tiffany C Scharschmidt Journal: Cell Rep Med Date: 2020-11-03